Global Hemoglobinopathies Market Size, Status and Forecast 2021-2027
- Published Date : 07-04-2021
- Pages : 96
- Report Id : 19206
- Categories : Healthcare
Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
In 2020, the global Hemoglobinopathies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Hemoglobinopathies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobinopathies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation
Market segment by Type, the product can be split into
By Type
By Therapy
Market segment by Application, split into
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hemoglobinopathies status, future forecast, growth opportunity, key market and key players.
To present the Hemoglobinopathies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hemoglobinopathies are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathies Market Size Growth Rate by Type (2016-2027)
1.4.2 Thalassemia
1.4.3 Sickle Cell Disease
1.4.4 Other Hb Variants Diseases
1.5 Market by Application
1.5.1 Global Hemoglobinopathies Market Share by Application (2021-2027)
1.5.2 Blood Testing
1.5.3 Genetic Testing
1.5.4 Pre-Implantation Genetic Diagnosis (PGD)
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hemoglobinopathies Market Size
2.2 Hemoglobinopathies Growth Trends by Regions
2.2.1 Hemoglobinopathies Market Size by Regions (2021-2027)
2.2.2 Hemoglobinopathies Market Share by Regions (2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Hemoglobinopathies Market Size by by Players
3.1.1 Global Hemoglobinopathies Revenue by by Players (2016-2021)
3.1.2 Global Hemoglobinopathies Revenue Market Share by by Players (2016-2021)
3.1.3 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.2 Hemoglobinopathies Key Players Head office and Area Served
3.3 Key Players Hemoglobinopathies Product/Solution/Service
3.4 Date of Enter into Hemoglobinopathies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hemoglobinopathies Market Size by Type (2016-2021)
4.2 Global Hemoglobinopathies Market Size by Application (2016-2021)
5 North America
5.1 North America Hemoglobinopathies Market Size (2016-2021)
5.2 Hemoglobinopathies Key Players in North America
5.3 North America Hemoglobinopathies Market Size by Type
5.4 North America Hemoglobinopathies Market Size by Application
6 Europe
6.1 Europe Hemoglobinopathies Market Size (2016-2021)
6.2 Hemoglobinopathies Key Players in Europe
6.3 Europe Hemoglobinopathies Market Size by Type
6.4 Europe Hemoglobinopathies Market Size by Application
7 China
7.1 China Hemoglobinopathies Market Size (2016-2021)
7.2 Hemoglobinopathies Key Players in China
7.3 China Hemoglobinopathies Market Size by Type
7.4 China Hemoglobinopathies Market Size by Application
8 Japan
8.1 Japan Hemoglobinopathies Market Size (2016-2021)
8.2 Hemoglobinopathies Key Players in Japan
8.3 Japan Hemoglobinopathies Market Size by Type
8.4 Japan Hemoglobinopathies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hemoglobinopathies Market Size (2016-2021)
9.2 Hemoglobinopathies Key Players in Southeast Asia
9.3 Southeast Asia Hemoglobinopathies Market Size by Type
9.4 Southeast Asia Hemoglobinopathies Market Size by Application
10 India
10.1 India Hemoglobinopathies Market Size (2016-2021)
10.2 Hemoglobinopathies Key Players in India
10.3 India Hemoglobinopathies Market Size by Type
10.4 India Hemoglobinopathies Market Size by Application
11 Central & South America
11.1 Central & South America Hemoglobinopathies Market Size (2016-2021)
11.2 Hemoglobinopathies Key Players in Central & South America
11.3 Central & South America Hemoglobinopathies Market Size by Type
11.4 Central & South America Hemoglobinopathies Market Size by Application
12 International Players Profiles
12.1 Gamida Cell
12.1.1 Gamida Cell Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hemoglobinopathies Introduction
12.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2016-2021))
12.1.5 Gamida Cell Recent Development
12.2 Alnylam Pharmaceuticals
12.2.1 Alnylam Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hemoglobinopathies Introduction
12.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021)
12.2.5 Alnylam Pharmaceuticals Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hemoglobinopathies Introduction
12.3.4 Sanofi Revenue in Hemoglobinopathies Business (2016-2021)
12.3.5 Sanofi Recent Development
12.4 Sangamo Therapeutics Inc.
12.4.1 Sangamo Therapeutics Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hemoglobinopathies Introduction
12.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2016-2021)
12.4.5 Sangamo Therapeutics Inc. Recent Development
12.5 Global Blood Therapeutics
12.5.1 Global Blood Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hemoglobinopathies Introduction
12.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2016-2021)
12.5.5 Global Blood Therapeutics Recent Development
12.6 Bluebird Bio
12.6.1 Bluebird Bio Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hemoglobinopathies Introduction
12.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2016-2021)
12.6.5 Bluebird Bio Recent Development
12.7 Emmaus Life Sciences Inc.
12.7.1 Emmaus Life Sciences Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hemoglobinopathies Introduction
12.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2016-2021)
12.7.5 Emmaus Life Sciences Inc. Recent Development
12.8 Prolong Pharmaceuticals
12.8.1 Prolong Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hemoglobinopathies Introduction
12.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2016-2021)
12.8.5 Prolong Pharmaceuticals Recent Development
12.9 Celgene Corporation
12.9.1 Celgene Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hemoglobinopathies Introduction
12.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2016-2021)
12.9.5 Celgene Corporation Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Product (2021-2027)
13.2 Market Size Forecast by Application (2021-2027)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Hemoglobinopathies Key Market Segments
Table Key Players Hemoglobinopathies Covered
Table Global Hemoglobinopathies Market Size Growth Rate by Type 2020-2027 (Million US$)
Figuer Thalassemia Figures
Table Key Players of Thalassemia
Figuer Sickle Cell Disease Figures
Table Key Players of Sickle Cell Disease
Figuer Other Hb Variants Diseases Figures
Table Key Players of Other Hb Variants Diseases
Table Global Hemoglobinopathies Market Size Growth by Application 2021-2027 (Million US$)
Figure Global Hemoglobinopathies Market Share by Application in 2020 & 2027
Figure Blood Testing Case Studies
Figure Genetic Testing Case Studies
Figure Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure Others Case Studies
Figure Hemoglobinopathies Report Years Considered
Figure Global Hemoglobinopathies Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Hemoglobinopathies Market Size by Regions 2021-2027 (Million US$)
Table Global Hemoglobinopathies Market Size by Regions 2021-2027 (Million US$)
Table Global Hemoglobinopathies Market Share by Regions 2016-2021
Figure Global Hemoglobinopathies Market Share by Regions 2016-2021
Figure Global Hemoglobinopathies Market Share by Regions in 2020
Table Market Top Trends
Table Key Drivers: Impact Analysis (2021-2027)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Hemoglobinopathies Revenue by by Players (2016-2021) (Million US$)
Table Global Hemoglobinopathies Market Share by by Players (2016-2021)
Figure Global Hemoglobinopathies Market Share by by Players in 2020
Table Global Hemoglobinopathies by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hemoglobinopathies Product/Solution/Service
Table Date of Enter into Hemoglobinopathies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hemoglobinopathies Market Size by Type (2016-2021) (Million US$)
Table Global Hemoglobinopathies Market Size Share by Type (2016-2021)
Figure Global Hemoglobinopathies Market Size Market Share by Type (2016-2021)
Table Global Hemoglobinopathies Market Size by Application (2016-2021) (Million US$)
Table Global Hemoglobinopathies Market Size Share by Application (2016-2021)
Figure Global Hemoglobinopathies Market Size Market Share by Application (2016-2021)
Figure Global Hemoglobinopathies Revenue Market Share by Application in 2020
Figure North America Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table North America Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table North America Key Players Hemoglobinopathies Market Share (2020-2021)
Table North America Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table North America Hemoglobinopathies Market Share by Type 2016-2021
Table North America Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table North America Hemoglobinopathies Market Share by Application 2016-2021
Figure Europe Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table Europe Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table Europe Key Players Hemoglobinopathies Market Share (2020-2021)
Table Europe Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table Europe Hemoglobinopathies Market Share by Type 2016-2021
Table Europe Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table Europe Hemoglobinopathies Market Share by Application 2016-2021
Figure China Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table China Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table China Key Players Hemoglobinopathies Market Share (2020-2021)
Table China Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table China Hemoglobinopathies Market Share by Type 2016-2021
Table China Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table China Hemoglobinopathies Market Share by Application 2016-2021
Figure Japan Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table Japan Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table Japan Key Players Hemoglobinopathies Market Share (2020-2021)
Table Japan Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table Japan Hemoglobinopathies Market Share by Type 2016-2021
Table Japan Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table Japan Hemoglobinopathies Market Share by Application 2016-2021
Figure Southeast Asia Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table Southeast Asia Key Players Hemoglobinopathies Market Share (2020-2021)
Table Southeast Asia Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table Southeast Asia Hemoglobinopathies Market Share by Type 2016-2021
Table Southeast Asia Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table Southeast Asia Hemoglobinopathies Market Share by Application 2016-2021
Figure India Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table India Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table India Key Players Hemoglobinopathies Market Share (2020-2021)
Table India Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table India Hemoglobinopathies Market Share by Type 2016-2021
Table India Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table India Hemoglobinopathies Market Share by Application 2016-2021
Figure Central & South America Hemoglobinopathies Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Hemoglobinopathies Revenue (2020-2021) (Million US$)
Table Central & South America Key Players Hemoglobinopathies Market Share (2020-2021)
Table Central & South America Hemoglobinopathies Market Size by Type 2016-2021 (Million US$)
Table Central & South America Hemoglobinopathies Market Share by Type 2016-2021
Table Central & South America Hemoglobinopathies Market Size by Application 2016-2021 (Million US$)
Table Central & South America Hemoglobinopathies Market Share by Application 2016-2021
Table Gamida Cell Company Details
Table Gamida Cell Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Gamida Cell Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Alnylam Pharmaceuticals Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Sanofi Recent Development
Table Sangamo Therapeutics Inc. Company Details
Table Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Sangamo Therapeutics Inc. Recent Development
Table Global Blood Therapeutics Company Details
Table Global Blood Therapeutics Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Global Blood Therapeutics Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Bluebird Bio Recent Development
Table Emmaus Life Sciences Inc. Company Details
Table Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Emmaus Life Sciences Inc. Recent Development
Table Prolong Pharmaceuticals Company Details
Table Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Prolong Pharmaceuticals Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Hemoglobinopathies Business 2016-2021 (Million US$)
Figure Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2016-2021)
Table Celgene Corporation Recent Development
Table Global Hemoglobinopathies Market Size by Regions (Million US$) 2021-2027
Figure Global Hemoglobinopathies Market Size Share by Regions (2021-2027)
Figure Global Hemoglobinopathies Market Size Share by Regions in 2027
Figure North America Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure Europe Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure China Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure Japan Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure India Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Hemoglobinopathies Market Size Forecast (2021-2027)(Million USD)
Table Global Hemoglobinopathies Market Size by Product (2021-2027) (Million US$)
Figure Global Hemoglobinopathies Market Size by Product (2021-2027)
Figure Global Hemoglobinopathies Market Size by Product in 2027
Table Global Hemoglobinopathies Market Size by Application (2021-2027) (Million US$)
Figure Global Hemoglobinopathies Market Size by Application (2021-2027)
Figure Global Hemoglobinopathies Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied ™ Copyright © 2025 .